CAS: 50595-15-8; Tert-Butyl 2-Hydroxyacetate

该化合物是有机化合物,其特性为酯性功能组,来源于甘蓝酸和丁基乙醇,其结构为三丁基乙醇,其特性为附于甘蓝藻的三丁基乙基,其特性一般为无色可粉色黄色,其味味色优美,其溶液在有机溶剂中无色可粉色,其溶液在各种应用中有用,包括溶剂和涂层及粘合剂的配制,第三丁基丁基化合物的存在会助长其阻塞性,从而影响其再活性和稳定性.此外,二丁基丁基甘可产生低挥发性,中度粘合物等特性,在工业应用中较为有利.在处理和接触准则方面,应参考安全数据,如任何化学物质一样.

结构式图片

相似化合物

623-50-7 79-14-1 96-35-5

欧盟法规

ECHA物质C&L通报

上下游产品

CAS号5292-43-3 溴乙酸叔丁酯 | CAS号107-59-5 氯乙酸叔丁酯 | CAS号6456-74-2 甘氨酸叔丁酯 | CAS号6297-93-4 2-(1,3-二氧代异吲哚啉-... | CAS号59854-04-5 O-Acetyl-glykol... | CAS号35059-50-8 重氮基乙酸叔丁酯

合成工艺路线路线简述

  • 合成目标产物 2-T-Butyl Glycolate 主要起始原料 Tert-Butyl Glycinate
  • (文献来源)合成步骤主要原料 Tert-Butyl Glycinate
氯乙酸叔丁酯置于c.I.酸性橙108,三乙胺体系中,用 N,N-二甲基甲酰胺 作为反应溶剂,化学反应生成 2-乙醇酸叔丁酯
参考文献:Kricheldorf,H.R.; Kaschig,J.,Justus Liebigs Annalen Der Chemie,1976,P. 882-890
标题:Kricheldorf,H.R.; Kaschig,J.,Justus Liebigs Annalen Der Chemie,1976,P. 882-890

海关参考信息

专利信息


专利号:US-11738092-B2
优先权日:2019-12-04
标题:Methods and compositions for synthesis of therapeutic nanoparticles
发明人:WYENT EMILY A; BLUMENFELD CARL M; LAMM ROBERT J
权利人:DANTARI INC
摘要:Improved methods and reactants for the chemical synthesis of therapeutic nanoparticles are provided. The nanoparticles comprise a polymeric core, to which is attached one or more homing molecules and one or more therapeutic agents. Improvements in speed, yield and purity are attained using the methods disclosed herein.

专利号:US-11306157-B2
优先权日:2018-12-21
标 题:Expedient synthesis of core disaccharide building blocks from natural polysaccharides for heparan sulfate oligosaccharide assembly
发明人:HSIEH-WILSON LINDA C; PAWAR NITIN J; WANG LEI
权利人:CALIFORNIA INST OF TECHN
摘要:Methods for the preparation of oligosaccharide products from polysaccharide starting materials are disclosed. The methods include: hydrolyzing a glucosamine-containing polysaccharide starting material, such as heparin or heparosan, under conditions sufficient to form an oligosaccharide intermediate (e.g., a GlcN-IdoA disaccharide intermediate or a GlcA-GlcN disaccharide intermediate), and converting the oligosaccharide intermediate to the oligosaccharide product. Conversion of the oligosaccharide intermediates to the oligosaccharide products may include one or more esterification, acylation, epimerization, protection, and deprotection steps. Preparation of higher-order oligomers is described, as well as methods for selective oligosaccharide sulfation.

专利号:US-4523022-A
优先权日:1983-07-07
标 题:Analogs of the antibiotic spectinomycin
发明人:THOMAS RICHARD C
权利人:UPJOHN CO
摘要:The present invention concerns the novel, sugar-ring expansion for synthesis of novel analogs of spectinomycin or C-6' analogs of spectinomycin from known aminomethyldihydrospectinomycin and analogs thereof. Additionally, the invention concerns the novel synthesis of novel 7 membered sugar-ring analogs of dihydrospectinomycin and C-6' analogs thereof from novel 7 membered sugar-ring spectinomycin and C-6' analogs thereof by treatment with NaBH4.

专利号:US-10858414-B2
优先权日:2018-03-09
标 题:Chemo-enzymatic synthesis of semaglutide, liraglutide and GLP-1
发明人:NUIJENS TIMO; TOPLAK ANA; QUAEDFLIEG PETER JAN LEONARD MARIO
权利人:ENZYPEP B V
摘要:The invention relates to a method for preparing a coupling product having the sequence P q -W v -His-X-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Val-Ser-Ser-Tyr-Leu-Glu-Gly-Gln-Ala-Ala-Y-Glu-Phe-Ile-Ala-Trp-Leu-Val-Z-Gly-Arg-Gly. The method includes enzymatically couplingn (a) a peptide C-terminal ester or thioester having a first peptide fragment represented by the formula P q -W v -His-X-Glu-(thio)ester; and (b) a peptide nucleophile having an N-terminally unprotected amine having a second peptide fragment with the sequence H-Gly-Thr-Phe-Thr-Ser-Asp-Val-Ser-Ser-Tyr-Leu-Glu-Gly-Gln-Ala-Ala-Y-Glu-Phe-Ile-Ala-Trp-Leu-Val-Z-Gly-Arg-Glyn whereinn P represents a protective group at the N-terminal α-amino function of the peptide C-terminal ester or thioester and q is an integer having a value of 1 or 0; W represents one or more amino acid residues, which may be the same or different and v is an integer having a value of 1 or more representing the number of amino acid residues W; X is Ala or an α-amino-isobutyric acid unit (Aib); Y is Lys, which Lys has a free side-chain ε-amino group or a side-chain ε-amino group that is protected with a protective group or a side-chain ε-amino group that is functionalized with an amino acid or another functional group; and n Z is Arg or Lys.

专利号:US-10266467-B2
优先权日:2017-08-02
标 题:Synthesis of glycols via transfer hydrogenation of alpha-functional esters with alcohols
发明人:CHAKRABORTY SUMIT; HEMBRE ROBERT THOMAS
权利人:EASTMAN CHEM CO
摘要:A transfer hydrogenation process for forming vicinal diols by hydrogenating 1,2-dioxygenated organic compounds using alcohols as the reducing agent instead of the traditional H 2 gas. The transfer hydrogenation is carried out under milder conditions of temperature and pressure than is typical for ester hydrogenation with H 2 . The milder conditions of operation provide benefits, such as lower operating and capital costs for industrial scale production as well as savings in product purification due to the avoidance of by-products from exposure of reaction mixtures and products to high temperatures.

专利号:US-10920258-B2
优先权日:2018-03-09
标题 :Chemo-enzymatic synthesis of semaglutide, liraglutide and GLP-1
发明人:NUIJENS TIMO; TOPLAK ANA; QUAEDFLIEG PETER JAN LEONARD MARIO
权利人:ENZYPEP B V
摘要:A method for synthesizing a peptide having the sequence His-X-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Val-Ser-Ser-Tyr-Leu-Glu-Gly-Gln-Ala-Ala-Y-Glu-Phe-Ile-Ala-Trp-Leu-Val-Z-Gly-Arg-Gly is disclosed. The method includes enzymatically coupling:n (a) a peptide C-terminal ester or thioester having a first peptide fragment with the sequence His-X-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Val-Ser-(thio)ester; and (b) a peptide nucleophile having an N-terminally unprotected amine having a second peptide fragment with the sequence H-Ser-Tyr-Leu-Glu-Gly-Gln-Ala-Ala-Y-Glu-Phe-Ile-Ala-Trp-Leu-Val-Z-Gly-Arg-Gly; wherein:n X is Ala or an α-amino-isobutyric acid (Aib) residue; Y is Lys, which Lys has a free side-chain ε-amino group or of which Lys the side-chain ε-amino group is protected with a protective group or of which Lys the side-chain ε-amino group is functionalized with an amino acid or another functional group; and Z is Arg or Lys.
嘉兴市吉拉特化工有限公司
⚠️ 未注册 · 未认证企业
⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
数据来源于公开网络搜索,平台未作核实,请自行辨别。
🏢敬请 企业认领
🏬开设公司展台
📢获取免费会员权益
🎖️点亮专属注册企业标签
📇展现公司完整信息 样本查看立即注册认领 →
网址: http://www.jlightchem.com
企业联系电话:0573-82813637;82813639👤
📞嘉兴市吉拉特化工有限公司 ⚠️参考联系方式
联系人:魏经理;王经理;叶经理
电话:0573-82813637;82813639
手机:13605839392;15857374971;15157377625
传真:0573-82813637
邮箱:sales@jlightchem.com
通信地址: 浙江省嘉兴市大桥镇嘉兴工业园区东塘支路北侧
邮编: 314006
🆔 联系时候可告知是从"百琢研"平台获取的信息.
⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

地址:浙江省嘉兴市大桥镇嘉兴工业园区东塘支路北侧
⚠️ 未注册 · 未认证企业
注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
常州市力仁医药科技有限公司
⚠️ 未注册 · 未认证企业
⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
数据来源于公开网络搜索,平台未作核实,请自行辨别。
🏢敬请 企业认领
🏬开设公司展台
📢获取免费会员权益
🎖️点亮专属注册企业标签
📇展现公司完整信息 样本查看立即注册认领 →
网址: http://www.lirenchem.com
电话:0519-85859058,13915836899👤
📞 常州市力仁医药科技有限公司⚠️参考联系方式

电话: 0519-85859058,13915836899
邮件:sales@lirenchem.com
网址: http://www.lirenchem.com
地址:江苏省常州市天宁区东仓桥弄1号
🆔 联系时候可告知是从"百琢研"平台获取的信息.
⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

江苏省常州市天宁区东仓桥弄1号
⚠️ 未注册 · 未认证企业
注册入口 备注: 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别. 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
第 1 / 1 页
现货

供应商参考报价(招募中)

品牌试剂参考报价(招募中)

📌 第三方产品分析报告

✅ COA系统入驻 | 共享模式

合成参考文献


参考文献:10.1055/s-0037-1611721
摘要:Engesser T, Brückner R. Stereoselective Aldol Additions of Glycolic Acid and Its Derivatives. Synthesis. 2019 Mar 25;51(08):1715–45. doi: 10.1055/s-0037-1611721.
📝 需求与反馈
尽可能描述清楚需求与问题信息
×

通知